The award selection process will consider scientific publications from research institutes in Germany which were published or accepted for publication in the years 2008 and 2009. The focus should be on successful transfer of research results into potential clinical applications. It is permitted to submit several publications with related content. For publications with multiple authors, please specify the candidate’s contribution to the publication. Applications by young scientists will be treated with preference. No more than ten years should have elapsed since receipt of the doctoral degree. Applications or nominations are requested to comprise a copy of the publication, brief Curriculum Vitae of the scientist, and his or her publication list of the past five years.
The award, which goes back to a foundation established by neurologist Walther Richtzenhain and his wife, is awarded annually, alternately to doctoral students at Heidelberg research institutes and to scientists from across Germany for publications in the area of translational cancer research. The award-winning publication is selected by a panel of experts; legal recourse is excluded. The award will be presented at a ceremonial scientific lecture event at DKFZ.
Applications or nominations are requested to be submitted in five copies on a CD including the required documents (application letter, CV, publication list including impact factors, and the publication itself) by June 30, 2010. In addition, a complete version on paper is required.
Please send the application package to:
Prof. Dr. Otmar D. Wiestler
Scientific Director of the German Cancer Research Center
P.O. Box 10 19 49
D-69009 Heidelberg
A picture for this press release is available at: www.dkfz.de/de/presse/pressemitteilungen/2010/images/Richtzenhain.jpg
Picture caption: Presentation of 2008 Richtzenhain Award: Professor Otmar D. Wiestler, Scientific Director of DKFZ (center), presenting the certificate to the two award winners, Professor Christopher Heeschen of the Spanish National Cancer Research Center (left) and Professor Stephan Stilgenbauer of Ulm University Hospitals (right).
Photography: Yan de Andres
Call for Proposals for 2010 Walther and Christine Richtzenhain-Award
The Management Board of the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) solicits applications and nominations from across Germany for this year’s sponsorship award of the Walther and Christine Richtzenhain Foundation. The € 10,000 award recognizes pioneering scientific publications in the area of translational cancer research.
About DKFZ
With more than 3,000 employees, the German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ) is Germany’s largest biomedical research institute. DKFZ scientists identify cancer risk factors, investigate how cancer progresses and develop new cancer prevention strategies. They are also developing new methods to diagnose tumors more precisely and treat cancer patients more successfully. The DKFZ's Cancer Information Service (KID) provides patients, interested citizens and experts with individual answers to questions relating to cancer.
To transfer promising approaches from cancer research to the clinic and thus improve the prognosis of cancer patients, the DKFZ cooperates with excellent research institutions and university hospitals throughout Germany:
- National Center for Tumor Diseases (NCT, 6 sites)
- German Cancer Consortium (DKTK, 8 sites)
- Hopp Children's Cancer Center (KiTZ) Heidelberg
- Helmholtz Institute for Translational Oncology (HI-TRON Mainz) - A Helmholtz Institute of the DKFZ
- DKFZ-Hector Cancer Institute at the University Medical Center Mannheim
- National Cancer Prevention Center (jointly with German Cancer Aid)
The DKFZ is 90 percent financed by the Federal Ministry of Education and Research and 10 percent by the state of Baden-Württemberg. The DKFZ is a member of the Helmholtz Association of German Research Centers.